ID   FCERA_RAT               Reviewed;         245 AA.
AC   P12371; P12840;
DT   01-OCT-1989, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1989, sequence version 1.
DT   24-JUL-2024, entry version 160.
DE   RecName: Full=High affinity immunoglobulin epsilon receptor subunit alpha;
DE   AltName: Full=Fc-epsilon RI-alpha;
DE            Short=FcERI;
DE   AltName: Full=IgE Fc receptor subunit alpha;
DE   Flags: Precursor;
GN   Name=Fcer1a; Synonyms=Fce1a;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=2959318; DOI=10.1021/bi00389a002;
RA   Kinet J.-P., Metzger H., Hakimi J., Kochan J.;
RT   "A cDNA presumptively coding for the alpha subunit of the receptor with
RT   high affinity for immunoglobulin E.";
RL   Biochemistry 26:4605-4610(1987).
RN   [2]
RP   SEQUENCE REVISION.
RA   Kochan J.;
RL   Submitted (MAR-1988) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Mast cell;
RX   PubMed=2964640; DOI=10.1073/pnas.85.6.1907;
RA   Shimizu A., Tepler I., Benfey P.N., Berenstein E.H., Siraganian R.P.,
RA   Leder P.;
RT   "Human and rat mast cell high-affinity immunoglobulin E receptors:
RT   characterization of putative alpha-chain gene products.";
RL   Proc. Natl. Acad. Sci. U.S.A. 85:1907-1911(1988).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2).
RX   PubMed=2969594; DOI=10.1073/pnas.85.15.5639;
RA   Liu F.-T., Albrandt K., Robertson M.W.;
RT   "cDNA heterogeneity suggests structural variants related to the high-
RT   affinity IgE receptor.";
RL   Proc. Natl. Acad. Sci. U.S.A. 85:5639-5643(1988).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-16, AND ALTERNATIVE SPLICING.
RX   PubMed=2522441; DOI=10.1016/s0021-9258(18)83636-5;
RA   Tepler I., Shimizu A., Leder P.;
RT   "The gene for the rat mast cell high affinity IgE receptor alpha chain.
RT   Structure and alternative mRNA splicing patterns.";
RL   J. Biol. Chem. 264:5912-5915(1989).
RN   [6]
RP   TISSUE SPECIFICITY, AND INDUCTION.
RX   PubMed=17728245; DOI=10.1074/jbc.m705950200;
RA   Ganguly S., Grodzki C., Sugden D., Moller M., Odom S., Gaildrat P.,
RA   Gery I., Siraganian R.P., Rivera J., Klein D.C.;
RT   "Neural adrenergic/cyclic AMP regulation of the immunoglobulin E receptor
RT   alpha-subunit expression in the mammalian pinealocyte: a
RT   neuroendocrine/immune response link?";
RL   J. Biol. Chem. 282:32758-32764(2007).
RN   [7]
RP   TISSUE SPECIFICITY, AND INDUCTION.
RX   PubMed=19103603; DOI=10.1074/jbc.m808394200;
RA   Bailey M.J., Coon S.L., Carter D.A., Humphries A., Kim J.S., Shi Q.,
RA   Gaildrat P., Morin F., Ganguly S., Hogenesch J.B., Weller J.L., Rath M.F.,
RA   Moller M., Baler R., Sugden D., Rangel Z.G., Munson P.J., Klein D.C.;
RT   "Night/day changes in pineal expression of >600 genes: central role of
RT   adrenergic/cAMP signaling.";
RL   J. Biol. Chem. 284:7606-7622(2009).
CC   -!- FUNCTION: High-affinity receptor for immunoglobulin epsilon/IgE.
CC       Mediates IgE effector functions in myeloid cells. Upon IgE binding and
CC       antigen/allergen cross-linking initiates signaling pathways that lead
CC       to myeloid cell activation and differentiation. On mast cells,
CC       basophils and eosinophils stimulates the secretion of vasoactive
CC       amines, lipid mediators and cytokines that contribute to inflammatory
CC       response, tissue remodeling and cytotoxicity against microbes. Triggers
CC       the immediate hypersensitivity response to allergens as a host defense
CC       mechanism against helminth parasites, pathogenic bacteria and venom
CC       toxicity. When dysregulated, it can elicit harmful life-threatening
CC       allergic and anaphylactic reactions. {ECO:0000250|UniProtKB:P12319}.
CC   -!- SUBUNIT: Tetramer of an alpha chain, a beta chain, and two disulfide
CC       linked gamma chains. Interacts with IGHE (via CH3 region).
CC       {ECO:0000250|UniProtKB:P12319}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250|UniProtKB:P12319};
CC       Single-pass type I membrane protein {ECO:0000255}.
CC   -!- SUBCELLULAR LOCATION: [Isoform 2]: Secreted.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P12371-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P12371-2; Sequence=VSP_012760, VSP_012761;
CC   -!- TISSUE SPECIFICITY: Expressed in leukocytes and pinealocytes at night
CC       (at protein level). {ECO:0000269|PubMed:17728245,
CC       ECO:0000269|PubMed:19103603}.
CC   -!- INDUCTION: Exhibits night/day variations with a 15-fold increased
CC       expression at night in the pineal gland. Up-regulation is due to a
CC       large degree to the release of norepinephrine from nerve terminals in
CC       the pineal gland and cAMP signaling pathway (at protein level).
CC       {ECO:0000269|PubMed:17728245, ECO:0000269|PubMed:19103603}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M17153; AAA42045.1; -; mRNA.
DR   EMBL; J03606; AAA41582.1; -; mRNA.
DR   EMBL; M21622; AAA41146.1; -; mRNA.
DR   EMBL; M21623; AAA41147.1; -; mRNA.
DR   PIR; C31327; A30154.
DR   PIR; D31327; D31327.
DR   RefSeq; NP_036856.1; NM_012724.4. [P12371-1]
DR   AlphaFoldDB; P12371; -.
DR   SMR; P12371; -.
DR   STRING; 10116.ENSRNOP00000069343; -.
DR   GlyCosmos; P12371; 7 sites, No reported glycans.
DR   GlyGen; P12371; 7 sites.
DR   PhosphoSitePlus; P12371; -.
DR   PaxDb; 10116-ENSRNOP00000054898; -.
DR   Ensembl; ENSRNOT00000104245.1; ENSRNOP00000092868.1; ENSRNOG00000009177.8. [P12371-1]
DR   Ensembl; ENSRNOT00055039310; ENSRNOP00055031894; ENSRNOG00055022890. [P12371-1]
DR   Ensembl; ENSRNOT00060045450; ENSRNOP00060037736; ENSRNOG00060026208. [P12371-1]
DR   Ensembl; ENSRNOT00065042397; ENSRNOP00065034688; ENSRNOG00065024682. [P12371-1]
DR   GeneID; 25047; -.
DR   KEGG; rno:25047; -.
DR   AGR; RGD:2597; -.
DR   CTD; 2205; -.
DR   RGD; 2597; Fcer1a.
DR   eggNOG; ENOG502RTXR; Eukaryota.
DR   GeneTree; ENSGT01050000244808; -.
DR   InParanoid; P12371; -.
DR   OMA; IRCHSWK; -.
DR   OrthoDB; 5261894at2759; -.
DR   PhylomeDB; P12371; -.
DR   Reactome; R-RNO-2454202; Fc epsilon receptor (FCERI) signaling.
DR   Reactome; R-RNO-2730905; Role of LAT2/NTAL/LAB on calcium mobilization.
DR   Reactome; R-RNO-2871796; FCERI mediated MAPK activation.
DR   Reactome; R-RNO-2871809; FCERI mediated Ca+2 mobilization.
DR   Reactome; R-RNO-2871837; FCERI mediated NF-kB activation.
DR   PRO; PR:P12371; -.
DR   Proteomes; UP000002494; Chromosome 13.
DR   GO; GO:0009986; C:cell surface; ISO:RGD.
DR   GO; GO:0009897; C:external side of plasma membrane; ISO:RGD.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0005886; C:plasma membrane; ISO:RGD.
DR   GO; GO:0019768; F:high-affinity IgE receptor activity; ISO:RGD.
DR   GO; GO:0019863; F:IgE binding; ISO:RGD.
DR   GO; GO:0019767; F:IgE receptor activity; ISO:RGD.
DR   GO; GO:0019722; P:calcium-mediated signaling; ISO:RGD.
DR   GO; GO:0007166; P:cell surface receptor signaling pathway; ISO:RGD.
DR   GO; GO:0043308; P:eosinophil degranulation; ISO:RGD.
DR   GO; GO:0051649; P:establishment of localization in cell; ISO:RGD.
DR   GO; GO:0006955; P:immune response; TAS:RGD.
DR   GO; GO:0016064; P:immunoglobulin mediated immune response; IBA:GO_Central.
DR   GO; GO:0019370; P:leukotriene biosynthetic process; ISO:RGD.
DR   GO; GO:0043303; P:mast cell degranulation; ISO:RGD.
DR   GO; GO:0050850; P:positive regulation of calcium-mediated signaling; ISO:RGD.
DR   GO; GO:0032725; P:positive regulation of granulocyte macrophage colony-stimulating factor production; ISO:RGD.
DR   GO; GO:0032752; P:positive regulation of interleukin-3 production; ISO:RGD.
DR   GO; GO:0032765; P:positive regulation of mast cell cytokine production; ISO:RGD.
DR   GO; GO:0043306; P:positive regulation of mast cell degranulation; ISO:RGD.
DR   GO; GO:0050731; P:positive regulation of peptidyl-tyrosine phosphorylation; ISO:RGD.
DR   GO; GO:0001812; P:positive regulation of type I hypersensitivity; ISO:RGD.
DR   GO; GO:0001820; P:serotonin secretion; ISO:RGD.
DR   GO; GO:0007165; P:signal transduction; ISO:RGD.
DR   GO; GO:0042092; P:type 2 immune response; ISO:RGD.
DR   GO; GO:0016068; P:type I hypersensitivity; ISO:RGD.
DR   CDD; cd05752; Ig1_FcgammaR_like; 1.
DR   CDD; cd05753; Ig2_FcgammaR_like; 1.
DR   Gene3D; 2.60.40.10; Immunoglobulins; 2.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR050488; Ig_Fc_receptor.
DR   InterPro; IPR003599; Ig_sub.
DR   PANTHER; PTHR11481:SF12; HIGH AFFINITY IMMUNOGLOBULIN EPSILON RECEPTOR SUBUNIT ALPHA; 1.
DR   PANTHER; PTHR11481; IMMUNOGLOBULIN FC RECEPTOR; 1.
DR   Pfam; PF13895; Ig_2; 1.
DR   SMART; SM00409; IG; 2.
DR   SUPFAM; SSF48726; Immunoglobulin; 2.
DR   PROSITE; PS50835; IG_LIKE; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell membrane; Disulfide bond; Glycoprotein;
KW   IgE-binding protein; Immunoglobulin domain; Membrane; Receptor;
KW   Reference proteome; Repeat; Secreted; Signal; Transmembrane;
KW   Transmembrane helix.
FT   SIGNAL          1..23
FT   CHAIN           24..245
FT                   /note="High affinity immunoglobulin epsilon receptor
FT                   subunit alpha"
FT                   /id="PRO_0000015163"
FT   TOPO_DOM        24..204
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        205..223
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        224..245
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          28..103
FT                   /note="Ig-like 1"
FT   DOMAIN          113..181
FT                   /note="Ig-like 2"
FT   CARBOHYD        52
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        53
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        58
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        65
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        123
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        158
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        167
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        49..91
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        130..174
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   VAR_SEQ         141..157
FT                   /note="VIYYKDDIAFKYSYDSN -> ITQLSIVGYNSFSHHWR (in isoform
FT                   2)"
FT                   /evidence="ECO:0000303|PubMed:2969594"
FT                   /id="VSP_012760"
FT   VAR_SEQ         158..245
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:2969594"
FT                   /id="VSP_012761"
SQ   SEQUENCE   245 AA;  27793 MW;  A0E67DD363B72197 CRC64;
     MDTGGSARLC LALVLISLGV MLTATQKSVV SLDPPWIRIL TGDKVTLICN GNNSSQMNST
     KWIHNDSISN VKSSHWVIVS ATIQDSGKYI CQKQGFYKSK PVYLNVMQEW LLLQSSADVV
     LDNGSFDIRC RSWKKWKVHK VIYYKDDIAF KYSYDSNNIS IRKATFNDSG SYHCTGYLNK
     VECKSDKFSI AVVKDYTIEY RWLQLIFPSL AVILFAVDTG LWFSTHKQFE SILKIQKTGK
     GKKKG
//
